01—Abstract
Summary
Summary of the 8-K filed February 4, 2026. Cited figures are marked; the original filing is the authoritative source.
Fortive Corporation reported fourth-quarter and full-year 2025 results on February 4, 2026, as furnished under Item 2.02 with the press release attached as Exhibit 99.1.
Fourth-quarter revenue was $1.12 billiona, up 4.6% year-over-year, with core revenue up 3.3%. GAAP net income was $192 million, down 0.9%, while adjusted EBITDA rose 7.8% to $358 million. GAAP diluted net EPS was $0.60, up 7.1%, and adjusted diluted net EPS was $0.90, up 12.5%.
Free cash flow for the quarter was $314 millionb. For full-year 2025, revenue was $4.16 billion, up 1.9% (core up 1.7%). GAAP net income was $533 million, up 10%, and adjusted EBITDA was $1,233 million, up 6.1%.
GAAP diluted net EPS was $1.59c, up 16.1%, and adjusted diluted net EPS was $2.71, up 12%. Free cash flow for the year was $931 million. The company deployed $1.6 billion on share repurchases in 2025, including an incremental $265 million in the fourth quarter, bringing second-half repurchases to about $1.3 billion, or roughly 26 million shares, described as about 8% of diluted shares outstanding.
Fortive initiated full-year 2026 adjusted diluted EPS guidance of $2.90 to $3.00d. Management stated that it is executing its Fortive Accelerated strategy and that its medium-term financial framework remains intact.
Segment results were mixed: Intelligent Operating Solutions grew Q4 revenue 5.3% to $770 million with a 37.4% adjusted EBITDA margin, while Advanced Healthcare Solutions grew revenue 3.2% to $353 million, with core growth of 1.6% and adjusted EBITDA margin down 150 basis points to 26.0%. Results are presented on a continuing operations basis following the June 28, 2025 separation of Ralliant Corporation.
02—Key points
Key Highlights
- Q4 2025 revenue of $1.12 billion rose 4.6% year-over-year, with core revenue up 3.3%.
- Q4 2025 adjusted diluted net EPS of $0.90 was up 12.5%, and GAAP diluted net EPS of $0.60 was up 7.1%.
- Full-year 2025 adjusted diluted net EPS of $2.71 was up 12%, and GAAP diluted net EPS of $1.59 was up 16.1%.
- Full-year 2025 free cash flow was $931 million, and GAAP operating cash flow was $1.0 billion.
- The company repurchased $1.6 billion of shares in 2025, including $265 million in Q4 and about $1.3 billion in the second half, representing about 8% of diluted shares outstanding.
- Initial FY 2026 adjusted EPS guidance is $2.90 to $3.00.
- Advanced Healthcare Solutions' Q4 adjusted EBITDA margin declined 150 basis points to 26.0%, while Intelligent Operating Solutions reached a 37.4% adjusted EBITDA margin.
03—Questions
Frequently Asked Questions
How did Fortive perform in the fourth quarter of 2025?
Revenue was $1.12 billion, up 4.6% year-over-year, with core revenue up 3.3%. GAAP net income was $192 million, down 0.9%, and adjusted EBITDA was $358 million, up 7.8%. Adjusted diluted net EPS was $0.90, up 12.5%.
What is Fortive's guidance for 2026?
Fortive anticipates full-year 2026 adjusted diluted net earnings per share of $2.90 to $3.00.
How much capital did Fortive return to shareholders through buybacks?
Fortive deployed $1.6 billion towards share repurchases in full-year 2025, including $265 million in the fourth quarter. Total second-half repurchases were about $1.3 billion, representing about 26 million shares or about 8% of diluted shares outstanding.
How did the two segments perform in Q4 2025?
Intelligent Operating Solutions revenue was $770 million, up 5.3% reported and 4.1% core, with a 37.4% adjusted EBITDA margin. Advanced Healthcare Solutions revenue was $353 million, up 3.2% reported and 1.6% core, with operating margin of 10.9% and adjusted EBITDA margin of 26.0%, down 150 basis points.
What is the Precision Technologies separation, and how does it affect these results?
On June 28, 2025, Fortive completed the separation of its former Precision Technologies segment by distributing all of the common stock of Ralliant Corporation to its shareholders. The Ralliant business is reported as discontinued operations, and all amounts in the release refer to continuing operations.
04—Continue